Theis Muncholm Thillemann

Weight-based cefuroxime dosing provides comparable orthopedic target tissue concentrations between weight groups – a microdialysis porcine study

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

Antibiotic prophylaxis is a key element in prevention of surgical site infections. For the majority of orthopedic procedures, antibiotic administration follows fixed dosing regimens irrespective of weight. However, this may result in insufficient antibiotic target tissue concentrations and higher risk of surgical site infections in obese individuals. The aim of this study was to investigate the effect of weight-based cefuroxime dosing on plasma and target tissue concentrations. Eighteen female pigs were allocated into three groups differentiated by weight: 53–57 kg, 73–77 kg, and 93–97 kg. Microdialysis catheters were placed for continuous sampling in bone, muscle, and subcutaneous tissue during an 8h sampling interval. Blood samples were collected as reference. Cefuroxime was administered intravenously as a bolus according to weight (20 mg/kg). The primary endpoint was the time above the cefuroxime minimal inhibitory concentration for Staphylococcus aureus (T > MIC (4 μg/mL)). Comparable target tissue T > MICs (4 μg/mL) were found between weight groups. Mean T > MIC ranged between 116–137 min for plasma, 118–154 min for bone, 109–146 min for the skeletal muscle, and 117–165 min for subcutaneous tissue across the groups. Weight-based cefuroxime (20 mg/kg) dosing approach provides comparable perioperative plasma and target tissue T > MIC (4 μg/mL) in animals between 50–100 kg body weight, and thus a comparable prophylaxis of surgical site infections.

OriginalsprogEngelsk
BogserieAPMIS
Vol/bind130
Nummer2
Sider (fra-til)111-118
Antal sider8
ISSN0903-4641
DOI
StatusUdgivet - feb. 2022

Bibliografisk note

Funding Information:
We would like to thank the Department of Clinical Medicine, the Surgical Research Laboratories, Aarhus University Hospital for supporting this study. This work was supported by the Novo Nordisk Foundation [NNF20OC0062032, 2020]. We are grateful for the financial support. The funding sources had no role in the study.

Funding Information:
We would like to thank the Department of Clinical Medicine, the Surgical Research Laboratories, Aarhus University Hospital for supporting this study. This work was supported by the Novo Nordisk Foundation [NNF20OC0062032, 2020]. We are grateful for the financial support. The funding sources had no role in the study.

Publisher Copyright:
© 2021 Scandinavian Societies for Medical Microbiology and Pathology

Se relationer på Aarhus Universitet Citationsformater

ID: 271998749